Credit Suisse Upgrades St Jude Medical To Neutral

Analysts at Credit Suisse upgraded

from Underperform to Neutral. The price target for St Jude Medical is set to $74. St Jude Medical shares have surged 8.98% over the past 52 weeks, while the S&P 500 index has gained 14.83% in the same period. St Jude Medical shares rose 0.34% to close at $68.17 on Friday.